WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

Name: WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy
License: Public Domain

West China Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

hepatocellular carcinoma (hcc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 154650
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.